Four studies examine how asthma education, access to advanced treatments and the risks of long-term steroid use can affect patient care, while highlighting gaps in recognizing uncontrolled asthma.
FAIRFAX, Va., Nov. 19, 2026 /PRNewswire/ -- Allergy & Asthma Network, a national leader in patient-centered research, education and advocacy, led and contributed to four research abstracts presented at the American College of Allergy, Asthma and Immunology (ACAAI) 2026 Annual Scientific Meeting, held November 12–16 at the Phoenix Convention Center in Phoenix, Arizona.
The research addressed important challenges in asthma care, including the need for education beyond medications, barriers to accessing advanced treatments, the risks and benefits of long-term steroid use, and the ongoing problem of unrecognized or undertreated asthma.
Together, the studies highlight the importance of understanding patients' experiences, improving access to care and ensuring that people living with asthma have the information and support they need to manage their condition.
Advancing Asthma Education Beyond Medication
"Beyond Pharmacotherapy: Providing Comprehensive Asthma Education Is Essential For Achieving Optimal Asthma Control"
Leandra Tonweber, PA-C, AE-C, Director of Community Support Programs; Mitu Patel, MPH, Data Insights and Analytics Manager; and De De Gardner, DrPH, RRT, FAARC, FCCP, Chief Research & Programs Officer, examined why education is an essential part of effective asthma management.
Medication is important for controlling asthma, but patients also need reliable information and practical tools to manage their condition. Education can help people better understand their symptoms, follow treatment plans and recognize when they may need additional care.
The research reinforces the importance of providing patients with comprehensive asthma education alongside prescribed treatments to support better disease management and informed healthcare decisions.
Exploring Barriers to Advanced Asthma Treatments
"Barriers to Biologic Medication Adoption for Patients with Uncontrolled and Severe Asthma"
Mitu Patel and De De Gardner conducted research examining why some patients with uncontrolled or severe asthma may face challenges accessing or starting biologic medications.
Biologics are advanced treatments that target specific parts of the immune system and can help certain patients with severe asthma. However, not everyone who might benefit from these medications is able to access or pursue them.
The abstract explores barriers that may affect treatment decisions and highlights the need to better understand patients' experiences. Addressing these challenges is an important part of helping people with severe asthma access appropriate treatment and participate in decisions about their care.
Examining the Benefits and Risks of Long-Term Steroid Use
"Maintenance Systemic Corticosteroids for the Management of Asthma: Systematic Review and Meta-Analysis of Randomized Controlled Trials"
De De Gardner contributed to a research collaboration examining the benefits and risks of long-term systemic corticosteroid use in asthma management. The study also included Allergy & Asthma Network patient partners Amanda Flowers, Hilarry Orr and Angel Melendez as coauthors, bringing patient perspectives into research that can inform treatment decisions.
Systemic corticosteroids, such as prednisone, are sometimes used long-term to manage severe asthma. However, prolonged use can cause serious side effects, making it important to understand whether the potential benefits outweigh the risks.
This research highlights the importance of carefully weighing treatment benefits against potential harm, while considering patient safety and long-term quality of life.
Identifying Gaps in Recognizing and Treating Uncontrolled Asthma
"Uncontrolled Symptomatic Asthma Remains Poorly Recognized and Undertreated: Evidence from a Global Patient Survey"
In collaboration with Sanofi, Mitu Patel and De De Gardner contributed to research examining how uncontrolled asthma is recognized and treated, drawing on the experiences of patients through a global survey.
People living with asthma may continue to experience symptoms even while receiving treatment. Recognizing when asthma is not well controlled is an important step toward ensuring patients receive the care they need.
The research examines gaps in identifying and treating uncontrolled asthma and emphasizes the value of listening to patients' experiences. It also highlights opportunities to improve communication between patients and healthcare professionals so that ongoing symptoms and treatment needs are better understood and addressed.
Connecting Research with Real-World Patient Needs
Together, the four abstracts reflect Allergy & Asthma Network's commitment to research that addresses real-world challenges and places patients at the center of asthma care.
"Improving asthma outcomes requires us to look beyond medications and better understand the challenges patients face in managing their condition," said Lynda Mitchell, MA, CAE, CEO of Allergy & Asthma Network. "From providing access to trusted education and appropriate treatments to recognizing when asthma remains uncontrolled, these are important issues that directly affect patients' health and quality of life. Our goal is to ensure patient experiences help inform research, clinical conversations and solutions that improve care."
Through research collaborations and partnerships with the scientific community, Allergy & Asthma Network works to turn evidence into practical education, advocacy and programs that help patients, caregivers and healthcare professionals make informed decisions and improve asthma care.
Media Story Opportunities
The research presented at ACAAI 2026 offers several timely story angles, including why medication alone may not be enough to control asthma, challenges patients face in accessing advanced treatments, the potential risks of long-term steroid use, and why uncontrolled asthma symptoms can go unrecognized or undertreated.
Members of the media are encouraged to contact Allergy & Asthma Network to explore these topics, request additional research findings, or arrange interviews with our experts and patient advocates. Our team can provide insights into the challenges people living with asthma face and opportunities to improve care and outcomes.
For interview requests or additional information, please contact Jennifer Wilson at [email protected].
About Allergy & Asthma Network
Founded in 1985, Allergy & Asthma Network is the leading nonprofit outreach, education, advocacy and research organization for people living with asthma, allergies and related conditions. Our mission is simple yet profound: to advance patient-centered research and advocate for better outcomes, access to care, education, and treatments that lead to improved health and quality of life. We specialize in making medically accurate information understandable to all, promoting evidence-based care, and fostering collaboration among patients, clinicians, researchers, advocates and policymakers. Learn more at AllergyAsthmaNetwork.org.
SOURCE Allergy & Asthma Network

Share this article